Fatemeh Ardeshir-Larijani

Fatemeh Ardeshir-Larijani

Oncology
1365 Clifton Road Northeast
BldgC
Atlanta, GA 30322

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications

Real-World Implementation of Tarlatamab-Dlle Therapy for Patients With Extensive-Stage Small Cell Lung Cancer and Other High-Grade Neuroendocrine Neoplasms.

Real-World Implementation of Tarlatamab-Dlle Therapy for Patients With Extensive-Stage Small Cell Lung Cancer and Other High-Grade Neuroendocrine Neoplasms.

Journal: JCO oncology practice
Published: July 08, 2026

Precision Oncology in Thymic Epithelial Tumors: Therapeutic Horizons and Implementation Barriers.

Precision Oncology in Thymic Epithelial Tumors: Therapeutic Horizons and Implementation Barriers.

Journal: International journal of molecular sciences
Published: June 27, 2026

Correction: Thymic epithelial tumors at the crossroads of immunity, autoimmunity, and immunotherapy.

Correction: Thymic epithelial tumors at the crossroads of immunity, autoimmunity, and immunotherapy.

Journal: Cancer immunology, immunotherapy : CII
Published: May 06, 2026

Thymic epithelial tumors at the crossroads of immunity, autoimmunity, and immunotherapy.

Thymic epithelial tumors at the crossroads of immunity, autoimmunity, and immunotherapy.

Journal: Cancer immunology, immunotherapy : CII
Published: December 24, 2025

Survival Determinants and Sociodemographic Disparities in Early-Onset Non-Small Cell Lung Cancer.

Survival Determinants and Sociodemographic Disparities in Early-Onset Non-Small Cell Lung Cancer.

Journal: JAMA network open
Published: October 13, 2025

Integrated molecular and clinical characterization of pulmonary large cell neuroendocrine carcinoma.

Integrated molecular and clinical characterization of pulmonary large cell neuroendocrine carcinoma.

Journal: Nature communications
Published: May 11, 2025

AI-based radiomic features predict outcomes and the added benefit of chemoimmunotherapy over chemotherapy in extensive stage small cell lung cancer: A multi-institutional study.

AI-based radiomic features predict outcomes and the added benefit of chemoimmunotherapy over chemotherapy in extensive stage small cell lung cancer: A multi-institutional study.

Journal: Cancer letters
Published: February 24, 2025

Tumor-to-tumor metastasis: case report of a neuroendocrine tumor of the lung metastasizing to a benign oncocytoma of the kidney.

Tumor-to-tumor metastasis: case report of a neuroendocrine tumor of the lung metastasizing to a benign oncocytoma of the kidney.

Journal: The Canadian journal of urology
Published: January 23, 2025

The MARIPOSA trials - implications for the treatment of EGFR-mutant NSCLC.

The MARIPOSA trials - implications for the treatment of EGFR-mutant NSCLC.

Journal: Nature reviews. Clinical oncology
Published: August 19, 2024

Trop-2 Expression and Its Impact on Survival in Thymic Epithelial Tumors: Brief Report.

Trop-2 Expression and Its Impact on Survival in Thymic Epithelial Tumors: Brief Report.

Journal: Clinical lung cancer
Published: August 25, 2023

Clinicogenomic Landscape of Metastatic Thymic Epithelial Tumors.

Clinicogenomic Landscape of Metastatic Thymic Epithelial Tumors.

Journal: JCO precision oncology
Published: February 14, 2023

A Phase II Trial of Atezolizumab Plus Carboplatin Plus Pemetrexed Plus Bevacizumab in the Treatment of Patients with Stage IV Non-Squamous Non-Small Cell Lung Cancer: Big Ten Cancer Research Consortium (BTCRC)- LUN 17-139.

A Phase II Trial of Atezolizumab Plus Carboplatin Plus Pemetrexed Plus Bevacizumab in the Treatment of Patients with Stage IV Non-Squamous Non-Small Cell Lung Cancer: Big Ten Cancer Research Consortium (BTCRC)- LUN 17-139.

Journal: Clinical lung cancer
Published: June 02, 2022
Showing 1-12 of 18

Last Updated: 09/26/2026